Change in visual function after macular translocation with 360deg; retinectomy for neovascular age-related macular degeneration

Ophthalmology

Volumn 111, Issue 9, 2004, Pages 1715-1724

  Mruthyunjaya, Prithvi ^a   Stinnett, Sandra S ^a   Toth, Cynthia A ^a,b,c  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b Duke University   (United States)

^c DUKE UNIVERSITY EYE CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

SILICONE OIL;

ADULT; AGED; ARTICLE; COMPARATIVE STUDY; EXTRAOCULAR MUSCLE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; RETINA DETACHMENT; RETINA MACULA DEGENERATION; RETINA MACULA TRANSLOCATION; RETINA NEOVASCULARIZATION; SUBRETINAL NEOVASCULARIZATION; TIME SERIES ANALYSIS; TREATMENT OUTCOME; VISION; VISUAL ACUITY; VISUAL IMPAIRMENT; FLUORESCENCE ANGIOGRAPHY; FOLLOW UP; PATHOPHYSIOLOGY; PHYSIOLOGY; PROSPECTIVE STUDY; RETINA MACULA LUTEA; TRANSPLANTATION; VISUAL DISORDER;

AGED; AGED, 80 AND OVER; CHOROIDAL NEOVASCULARIZATION; FEMALE; FLUORESCEIN ANGIOGRAPHY; FOLLOW-UP STUDIES; HUMANS; MACULA LUTEA; MACULAR DEGENERATION; MALE; POSTOPERATIVE COMPLICATIONS; PROSPECTIVE STUDIES; SILICONE OILS; VISION DISORDERS; VISUAL ACUITY;

EID: 4444335505     PISSN: 01616420     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ophtha.2004.03.022     Document Type: Article

References (34)

1. Ambati J., Ambati B.K., Yoo S.H., et al. Age-related macular degeneration etiology, pathogenesis, and the therapeutic strategies. Surv Ophthalmol. 48:2003;257-293
2. Treatment of Age-Related Macular Degeneration with Photodynamic Therapy (TAP) Study Group. Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin. One-year results of 2 randomized clinical trials - TAP report 1. Arch Ophthalmol. 117:1999;1329-1345
3. Verteporfin in Photodynamic Therapy Study Group. Verteporfin therapy of subfoveal choroidal neovascularization in age-related macular degeneration two-year results of a randomized clinical trial including lesions with occult with no classic choroidal neovascularization - Verteporfin in Photodynamic Therapy report 2. Am J Ophthalmol. 131:2001;541-560
4. Treatment of Age-Related Macular Degeneration with Photodynamic Therapy and Verteporfin in Photodynamic Therapy Study Groups. Effect of lesion size, visual acuity, and lesion composition on visual acuity change with and without verteporfin therapy for choroidal neovascularization secondary to age-related macular degeneration TAP and VIP report no. 1. Am J Ophthalmol. 136:2003;407-418
5. Schmit-Erfurth U.M., Michels S. Changes in confocal indocyanine green angiography through two years after photodynamic therapy with verteporfin. Ophthalmology. 110:2003;1306-1314
6. American Academy of Ophthalmology. Ophthalmic procedure preliminary assessment. Macular translocation. Ophthalmology. 107:2000;1015-1018
7. Machemer R. Macular translocation. Am J Ophthalmol. 125:1998;698-700
8. Machemer R., Steinhorst U.H. Retinal separation, retinotomy, and macular relocation II. A surgical approach for age-related macular degeneration? Graefes Arch Clin Exp Ophthalmol. 231:1993;635-641
9. Seaber J.H., Machemer R. Adaptation to monocular torsion after macular translocation. Graefes Arch Clin Exp Ophthalmol. 235:1997;76-81
10. Eckardt C., Eckardt U., Conrad H.G. Macular rotation with and without counter-rotation of the globe in patients with age-related macular degeneration. Graefes Arch Clin Exp Ophthalmol. 237:1999;313-325
11. Toth C.A., Freedman S.F. Macular translocation with 360-degree peripheral retinectomy impact of technique and surgical experience on visual outcomes. Retina. 21:2001;293-303
12. Lai J.C., Lapolice D.J., Stinnett S.S., et al. Visual outcomes following macular translocation with 360-degree peripheral retinectomy. Arch Ophthalmol. 120:2002;1317-1324
13. Submacular Surgery Trials (SST). Manual of Procedures. NTIS order no. PB98-166648. 1998;National Technical Information Service, Springfield, VA
14. Freedman S.F., Rojas M., Toth C.A. Strabismus surgery for large-angle cyclotorsion after macular translocation surgery. J AAPOS. 6:2002;154-162
15. Freedman S.F., Seaber J.H., Buckley E.G., et al. Combined superior oblique muscle recession and inferior oblique muscle advancement and transposition for cyclotorsion associated with macular translocation surgery. J AAPOS. 4:2000;75-83
16. Whittaker S.G., Lovie-Kitchin J. Visual requirements for reading. Optom Vis Sci. 70:1993;54-65
17. Fujikado T., Asonuma S., Ohji M., et al. Reading ability after macular translocation surgery with 360-degree retinotomy. Am J Ophthalmol. 134:2002;849-856
18. Aisenbrey S., Lafaut B.A., Szurman P., et al. Macular translocation with 360-degree retinotomy for exudative age-related macular degeneration. Arch Ophthalmol. 120:2002;451-459
19. Abdel-Meguid A., Lappas A., Hartmann K., et al. One year follow up of macular translocation with 360 degree retinotomy in patients with age related macular degeneration. Br J Ophthalmol. 87:2003;615-621
20. Pertile G., Claes C. Macular translocation with 360 degree retinotomy for management of age-related macular degeneration with subfoveal choroidal neovascularization. Am J Ophthalmol. 134:2002;560-565
21. Ohji M., Fujikado T., Kusaka S., et al. Comparison of three techniques of foveal translocation in patients with subfoveal choroidal neovascularization resulting from age-related macular degeneration. Am J Ophthalmol. 132:2001;888-896
22. Thomas M.A., Dickinson J.D., Melberg N.S., et al. Visual results after surgical removal of subfoveal choroidal neovascular membranes. Ophthalmology. 101:1994;1384-1396
23. Haupert C.L., McCuen B.W. II, Jaffe G.J., et al. Pars plana vitrectomy, subretinal injection of tissue plasminogen activator, and fluid-gas exchange for displacement of thick submacular hemorrhage in age-related macular degeneration. Am J Ophthalmol. 131:2001;208-215
24. Hassan A.S., Johnson M.W., Schniederman T.E., et al. Management of submacular hemorrhage with intravitreous tissue plasminogen activator injection and pneumatic displacement. Ophthalmology. 106:1999;1900-1906. Discussion 1906-7
25. Binder S., Stolba U., Krebs I., et al. Transplantation of autologous retinal pigment epithelium in eyes with foveal neovascularization resulting from age-related macular degeneration a pilot study. Am J Ophthalmol. 133:2002;215-225
26. MacMillan E.S., Elliot D.B., Patel B., Cox M. Loss of visual acuity is the main reason why reading addition increased after the age of sixty. Optom Vis Sci. 78:2001;381-385
27. Wolf S., Lappas A., Weinberger A.W., Kirchhof B. Macular translocation for surgical management of subfoveal choroidal neovascularization in patients with AMD first results. Graefes Arch Clin Exp Ophthalmol. 237:1999;51-57
28. Age-Related Eye Disease Study Research Group. A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss AREDS report no. 8. Arch Ophthalmol. 119:2001;1417-1436
29. Algvere P.V., Libert C., Lindgarde G., Seregard S. Transpupillary thermotherapy of predominately occult choroidal neovascularization in age-related macular degeneration with 12 months follow-up. Acta Ophthalmol Scand. 81:2003;110-117
30. Anecortave Acetate Clinical Studies Group. Anecortave acetate as monotherapy for the treatment of subfoveal lesions in patients with exudative age-related macular degeneration (AMD) interim (month 6) analysis of clinical safety and efficacy. Retina. 23:2003;14-23
31. Krzystolik M.G., Afshari M.A., Adamis A.P., et al. Prevention of experimental choroidal neovascularization with intravitreal anti-vascular endothelial growth factor antibody fragment. Arch Ophthalmol. 120:2002;338-346
32. Reichel E., Berrocal A.M., Ip M., et al. Transpupillary thermotherapy of occult subfoveal choroidal neovascularization in patients with age-related macular degeneration. Ophthalmology. 106:1999;1908-1914
33. Anecortave Acetate Clinical Studies Group. Anecortave acetate as monotherapy for treatment of subfoveal neovascularization in age-related macular degeneration twelve-month clinical outcomes. Ophthalmology. 110:2003;2372-2383
34. Eyetech Study Group. Anti-vascular endothelial growth factor therapy for subfoveal choroidal neovascularization secondary to age-related macular degeneration phase II study results. Ophthalmology. 110:2003;979-986